Visual Process Monitoring by Data-Dependent Kernel Discriminant Analysis with t-Distributed Similarities. [PDF]
Wei C, Wen C, He J, Song Z.
europepmc +1 more source
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
From Eyes to Cameras to Kinetics: Computer Vision for Chemical Process Monitoring. [PDF]
Barrington H +5 more
europepmc +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
OD-ViTFScL: Asynchronous Few-Shot Continual Learning for Intelligent Process Monitoring and Fault Diagnosis in Petrochemical Plants. [PDF]
Oshidele O, Lin S.
europepmc +1 more source
Prescriptive process monitoring: <i>Quo vadis</i>? [PDF]
Kubrak K, Milani F, Nolte A, Dumas M.
europepmc +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Development and Validation of an Antigen-Capture ELISA for Quantitative Detection of Donkey-Origin Rotavirus: Application in Vaccine Manufacturing Process Monitoring. [PDF]
Zhang Z +9 more
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Development of a Jacketed Breathable Shake Flask With Process Monitoring, Control, and Bioreactor-Like Performance. [PDF]
Kumar V +5 more
europepmc +1 more source

